Amneal Pharmaceuticals Plans $120 Million Investment, Creating More Than 500 Jobs In Three States
08/08/2012
The company currently employs over 1100 people in the United States. Amneal officials said in the next two years facility enlargements and resulting jobs increase will generate an estimated $21 million per year in additional payroll and other benefits to local economies.
The capital investment in its manufacturing plants and other facilities will support the firm's expansion into new products such as high potency medications, controlled substances and softgel capsules; new dosage forms including transdermal patches and injectables; and new therapeutic areas like oncology.
Driving further expansion in the U.S. market, Amneal is committed to spending 15 to 20 percent of annual revenue on research and Development, while the industry norm is 5 to 6 percent.
"This major investment in our U.S. operations will more than double Amneal's production volume and add hundreds of jobs while maintaining our dedication to superior quality in our products as well as throughout our organization," said Chintu Patel, Amneal CEO. "It enables us to significantly diversify our generics portfolio, further expanding the value we provide our customers."
"We clearly understand the value of, and are fully committed to, investing and growing within the market we serve, significantly expanding our number of `Made in the USA' products," said Chirag Patel, Amneal President. "Generic pharmaceuticals ensure the lowest cost of medications to help make healthcare more affordable to all consumers."
Project Announcements
Little Leaf Farms Plans Coffee County, Tennessee, Production Operations
07/02/2025
White Rock Truss & Components Expands Lee County, Virginia, Operations
07/02/2025
Fox Tank Company Plans Coshocton, Ohio, Operations
07/02/2025
Ascentek Expands Shreveport, Louisiana, Operations
07/02/2025
ProBio Establishes Hopewell, New Jersey, Gene Therapy Operations
07/02/2025
22nd Century Technologies Expands Fairfax County, Virginia, Headquarters Operations
07/02/2025
Most Read
-
20th Annual Area Development Gold and Silver Shovel Awards
Q2 2025
-
First Person: Joe Capes, CEO, LiquidStack
Q2 2025
-
The Legal Limits of DEI in Incentives Agreements, Hiring, and Contracting
Q2 2025
-
From Silicon to Server: Mapping the Data Center Supply Chain
Q2 2025
-
39th Annual Corporate & 21st Annual Consultants Surveys: What Business Leaders and Consultants Are Saying About Site Selection
Q1 2025
-
Rethinking Life Sciences Site Selection in a Resilient and Dynamic Market
Q2 2025
-
First Person: David Robey, Co-CEO of QTS Data Centers
Q2 2025